EVALUATION OF DIFFERENT PROPHYLACTIC INTERVENTIONS TOWARD COVID-19 IN SOLID ORGAN TRANSPLANT PATIENTS

Conditions

• COVID-19 Pandemic
• Transplant-Related Disorder

Interventions

• DRUG: tixagevimab-cilgavimab(AZD7442, AstraZeneca)

Sponsor

University of Rome Tor Vergata